Pfizer Inc. v. Mylan Pharmaceuticals Inc.
Pfizer Inc. v. Mylan Pharmaceuticals Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
PFIZER INC., PHARMACIA & UPJOHN COMPANY, PHARMACIA & UPJOHN COMPANY LLC, SUGEN, INC., C.P. PHARMACEUTICALS INTERNATIONAL C.V., PFIZER PHARMACEUTICALS LLC, PF PRISM C.V., Plaintiffs-Appellees
v.
MYLAN PHARMACEUTICALS INC., Defendant-Appellant ______________________
2015-1131 ______________________
Appeal from the United States District Court for the District of Delaware in No. 1:10-cv-00528-GMS, Judge Gregory M. Sleet. ______________________
JUDGMENT ______________________
THOMAS H.L. SELBY, Williams & Connolly LLP, Wash- ington, DC, argued for plaintiffs-appellees. Also repre- sented by STANLEY E. FISHER, JESSAMYN SHELI BERNIKER, SARA KAISER CREIGHTON. DOUGLAS H. CARSTEN, Wilson, Sonsini, Goodrich & Rosati, PC, San Diego, CA, argued for defendant- appellant. Also represented by PETER SOO KANG; KATHERINE HASPER, Palo Alto, CA; ROBERT DELAFIELD, Austin, TX. ______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (DYK, WALLACH, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
January 13, 2016 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court
Reference
- Status
- Unpublished